Bibliography
- Garrod D, Chidgey M. Desmosome structure, composition and function. Biochim Biophys Acta 2008;1778:572-87
- Amagai M, Stanley JR. Desmoglein as a target in skin disease and beyond. J Invest Dermatol 2012;132:776-84
- Koga H, Tsuruta D, Ohyama B, Desmoglein 3, its pathogenecity and a possibility for therapeutic target in pemphigus vulgaris. Expert Opin Ther Targets 2013;17(3):293-306
- Dusek RL, Attardi LD. Desmosomes: new perpetrators in tumour suppression. Nat Rev Cancer 2011;11:317-23
- Hiraki A, Shinohara M, Ikebe T, Immunohistochemical staining of desmosomal components in oral squamous cell carcinomas and its association with tumour behaviour. Br J Cancer 1996;73:1491-7
- Wang L, Liu T, Wang Y, Altered expression of desmocollin 3, desmoglein 3, and beta-catenin in oral squamous cell carcinoma: correlation with lymph node metastasis and cell proliferation. Virchows Arch 2007;451:959-66
- Chen YJ, Chang JT, Lee L, DSG3 is overexpressed in head neck cancer and is a potential molecular target for inhibition of oncogenesis. Oncogene 2007;26:467-76
- Baron S, Hoang A, Vogel H, Attardi LD. Unimpaired skin carcinogenesis in desmoglein 3 knockout mice. PLoS One 2012;7:e50024
- Chung CH, Parker JS, Karaca G, Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell 2004;5:489-500
- Beaudry VG, Jiang D, Dusek RL, Loss of the p53/p63 regulated desmosomal protein Perp promotes tumorigenesis. PLoS Genet 2010;6:e1001168